Johnson & Johnson to acquire Abiomed for $16.6B
Johnson & Johnson has made its move on M&A, announcing today that it will acquire Abiomed for approximately $16.6 billion.
Source: massdevice.com
Stay updated with breaking news from Michael Bodner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson has made its move on M&A, announcing today that it will acquire Abiomed for approximately $16.6 billion.
Johnson & Johnson entered into a definitive agreement to acquire medical technology company Abiomed for approximately $16.6 billion.
Transaction to bring lifesaving innovations to more patients with unmet need
Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTARâ„¢ Balloon Ablation Catheter.